Sinha Rajesh, Anjum Shahnaz, Gupta Kartikeya, Agarwal Tushar, Sharma Namrata, Nair Sridevi, Kapoor Shrishti, Titiyal Jeewan S
Division of Cornea, Cataract and Refractive Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol. 2025 Jul 1;73(7):974-979. doi: 10.4103/IJO.IJO_2139_24. Epub 2025 Apr 17.
To study the outcomes of femtosecond laser-assisted intrastromal negative meniscus lenticule implantation with accelerated corneal collagen crosslinking (FILAC) in advanced keratoconus.
A prospective, interventional study evaluated the outcomes of FILAC in eyes with progressive keratoconus of Amsler-Krumeich stage 4 with thinnest pachymetry of 320-400 microns. A total of 10 eyes of 10 patients were enrolled. A negative meniscus allogenic stromal lenticule of 8.5 mm diameter was implanted into a corneal pocket created by a femtosecond laser at 150 microns depth and simultaneous accelerated corneal collagen crosslinking (CXL). Outcomes assessed 12 months after the procedure included uncorrected distance visual acuity (UDVA) and best-corrected visual acuity (BCVA), subjective refraction, and corneal topography changes.
Mean UDVA improved from baseline to 12 months follow-up (1.43 ± 0.39 vs. 1.32 ± 0.31 logMAR, P = 0.49). Four patients did not accept contact lenses preoperatively, whereas all patients were successfully fitted with semi-scleral contact lenses postoperatively with a mean BCVA of 0.47 ± 0.14 logMAR at 12 months. Mean corneal topographic values showed improvement from baseline to 12 months follow-up: K1 (58.44 ± 5.59 to 55.57 ± 5.68), K2 (63.35 ± 6.86 to 59.35 ± 7.1), Kmax (71.07 ± 7.95 to 66.29 ± 7.54) and astigmatism (4.89 ± 3.35 to 3.88 ± 2.35) ( P > 0.05). The mean thinnest pachymetry improved significantly from baseline to 12 months follow-up (354.9 ± 28.52 vs. 462.5 ± 36.30 microns, P = 0.0001). There was a non-significant improvement in subjective refraction and aberrometry.
This technique effectively halts disease progression and improves visual outcomes in advanced keratoconus.
研究飞秒激光辅助基质内负弯月形透镜植入联合加速角膜胶原交联(FILAC)治疗重度圆锥角膜的效果。
一项前瞻性干预性研究评估了FILAC对Amsler-Krumeich 4期进行性圆锥角膜、最薄角膜厚度为320 - 400微米的患者的治疗效果。共纳入10例患者的10只眼。将直径8.5毫米的异体基质负弯月形透镜植入飞秒激光在150微米深度创建的角膜袋内,并同时进行加速角膜胶原交联(CXL)。术后12个月评估的结果包括未矫正远视力(UDVA)、最佳矫正视力(BCVA)、主观验光和角膜地形图变化。
从基线到术后12个月随访,平均UDVA有所改善(1.43±0.39对1.32±0.31 logMAR,P = 0.49)。4例患者术前不接受佩戴隐形眼镜,而所有患者术后均成功佩戴半巩膜隐形眼镜,术后12个月时平均BCVA为0.47±0.14 logMAR。从基线到术后12个月随访,平均角膜地形图值有所改善:K1(58.44±5.59至55.57±5.68)、K2(63.35±6.86至59.35±7.1)、Kmax(71.07±7.95至66.29±7.54)和散光(4.89±3.35至3.88±2.35)(P>0.05)。从基线到术后12个月随访,平均最薄角膜厚度显著改善(354.9±28.52对462.5±36.30微米,P = 0.0001)。主观验光和像差测量有不显著的改善。
该技术可有效阻止重度圆锥角膜疾病进展并改善视力预后。